
An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025
Isomorphic Labs, a young company whose artificial intelligence technology for drug research has already landed partnerships with big pharmaceutical companies, unveiled $600 million in new financing this week as it looks to advance its own drug pipeline. …